Literature DB >> 18313529

The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.

Zhixiong Lin1, James Mechalakos, Sadek Nehmeh, Heiko Schoder, Nancy Lee, John Humm, C Clifton Ling.   

Abstract

PURPOSE: To evaluate how changes in tumor hypoxia, according to serial fluorine-18-labeled fluoro-misonidazole (18F-FMISO) positron emission tomography (PET) imaging, affect the efficacy of intensity-modulated radiotherapy (IMRT) dose painting. METHODS AND MATERIALS: Seven patients with head and neck cancers were imaged twice with FMISO PET, separated by 3 days, before radiotherapy. Intensity-modulated radiotherapy plans were designed, on the basis of the first FMISO scan, to deliver a boost dose of 14 Gy to the hypoxic volume, in addition to the 70-Gy prescription dose. The same plans were then applied to hypoxic volumes from the second FMISO scan, and the efficacy of dose painting evaluated by assessing coverage of the hypoxic volumes using Dmax, Dmin, Dmean, D95, and equivalent uniform dose (EUD).
RESULTS: Similar hypoxic volumes were observed in the serial scans for 3 patients but dissimilar ones for the other 4. There was reduced coverage of hypoxic volumes of the second FMISO scan relative to that of the first scan (e.g., the average EUD decreased from 87 Gy to 80 Gy). The decrease was dependent on the similarity of the hypoxic volumes of the two scans (e.g., the average EUD decrease was approximately 4 Gy for patients with similar hypoxic volumes and approximately 12 Gy for patients with dissimilar ones).
CONCLUSIONS: The changes in spatial distribution of tumor hypoxia, as detected in serial FMISO PET imaging, compromised the coverage of hypoxic tumor volumes achievable by dose-painting IMRT. However, dose painting always increased the EUD of the hypoxic volumes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313529      PMCID: PMC3784985          DOI: 10.1016/j.ijrobp.2007.09.050

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  31 in total

1.  Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

Authors:  Nancy Lee; Ping Xia; Jeanne M Quivey; Khalil Sultanem; Ian Poon; Clayton Akazawa; Pam Akazawa; Vivian Weinberg; Karen K Fu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

2.  Intratumoral pO2 histography as predictive assay in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; P G Knapstein; P Vaupel
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

3.  Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.

Authors:  Richard A Popple; Roger Ove; Sui Shen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

4.  Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.

Authors:  Joseph G Rajendran; David L Schwartz; Janet O'Sullivan; Lanell M Peterson; Patrick Ng; Jeffrey Scharnhorst; John R Grierson; Kenneth A Krohn
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

5.  Intermittent blood flow in a murine tumor: radiobiological effects.

Authors:  D J Chaplin; P L Olive; R E Durand
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

6.  In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.

Authors:  Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

7.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.

Authors:  Nancy Y Lee; James G Mechalakos; Sadek Nehmeh; Zhixiong Lin; Olivia D Squire; Shangde Cai; Kelvin Chan; Pasquale B Zanzonico; Carlo Greco; Clifton C Ling; John L Humm; Heiko Schöder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

8.  Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.

Authors:  K S Clifford Chao; Gokhan Ozyigit; Binh N Tran; Mustafa Cengiz; James F Dempsey; Daniel A Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-02-01       Impact factor: 7.038

9.  Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

Authors:  Sadek A Nehmeh; Nancy Y Lee; Heiko Schröder; Olivia Squire; Pat B Zanzonico; Yusuf E Erdi; Carlo Greco; Gig Mageras; Hai S Pham; Steve M Larson; Clifton C Ling; John L Humm
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-01       Impact factor: 7.038

10.  Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.

Authors:  Nancy Lee; Ping Xia; Nancy J Fischbein; Pam Akazawa; Clayton Akazawa; Jeanne M Quivey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-09-01       Impact factor: 7.038

View more
  49 in total

1.  A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management.

Authors:  Michael W Kissick; Xiaohu Mo; Keisha C McCall; Leah K Schubert; David C Westerly; Thomas R Mackie
Journal:  Phys Med Biol       Date:  2010-04-30       Impact factor: 3.609

2.  Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice.

Authors:  Hironobu Yasui; Shingo Matsumoto; Nallathamby Devasahayam; Jeeva P Munasinghe; Rajani Choudhuri; Keita Saito; Sankaran Subramanian; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

3.  Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.

Authors:  Tyler J Bradshaw; Stephen Yip; Ngoneh Jallow; Lisa J Forrest; Robert Jeraj
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-28       Impact factor: 7.038

4.  Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.

Authors:  David J Carlson; Paul J Keall; Billy W Loo; Zhe J Chen; J Martin Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-22       Impact factor: 7.038

5.  Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.

Authors:  Olivia J Kelada; Sara Rockwell; Ming-Qiang Zheng; Yiyun Huang; Yanfeng Liu; Carmen J Booth; Roy H Decker; Uwe Oelfke; Richard E Carson; David J Carlson
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

6.  Broadening the scope of image-guided radiotherapy (IGRT).

Authors:  Carlo Greco; C Clifton Ling
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

Review 7.  Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview.

Authors:  Punit Sharma; Anirban Mukherjee
Journal:  Ann Transl Med       Date:  2016-02

Review 8.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 9.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 10.  Tumor hypoxia: a new PET imaging biomarker in clinical oncology.

Authors:  Nagara Tamaki; Kenji Hirata
Journal:  Int J Clin Oncol       Date:  2015-11-14       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.